Although fragile X syndrome (FXS) is the commonest cause of inherited intellectual disability the mean age of diagnosis in Australia is 5.5 years. Newborn screening for FXS can provide an early diagnosis, preventing the "diagnostic odyssey", allowing access to early interventions, and providing reproductive information for parents. Parents of affected children support newborn screening, but few clinical studies have evaluated community attitudes. A pilot study in 2009-2010 was performed in a tertiary hospital to explore feasibility and maternal attitudes. FXS testing of male and female newborns was offered to mothers in addition to routine newborn screening. Mothers were provided with information about FXS, inheritance pattern, carrier status, and associated adult-onset disorders. One thousand nine hundred seventy-one of 2,094 mothers (94%) consented to testing of 2,000 newborns. 86% completed the attitudinal survey and 10% provided written comments. Almost all parents (99%) elected to be informed of both premutation and full mutation status and there was little concern about identification of carrier status or associated adult-onset disorders. Most mothers (96%) were comfortable being approached in the postnatal period and supported testing because no extra blood test was required. Mothers considered an early diagnosis beneficial to help prepare for a child with additional needs (93%) and for reproductive planning (64%). Some were anxious about the potential test results (10%) and others felt their feelings towards their newborn may change if diagnosed with FXS (16%). High participation rates and maternal attitudes indicate a high level of maternal acceptance and voluntary support for newborn screening for FXS.
This paper explores multilingual hospital encounters in which medical professionals and patients do not speak the same language, and where interpreting is facilitated through the use of video technology. The participants use video technology to create an interactional space for interpreting. While video technology affords the participants visual access to each other, and the participants may use embodied actions in interaction, participants in interaction do not necessarily organise their interactional space in ways that secure congruent views of each other. While the participants’ incongruent views of each other may cause problems in the organisation of interaction, the participants rarely discuss the visual setting. This article explores how the participants orient to the visual materiality of the setting and how they use the visual ecology they create, in and through the interaction, to best achieve the multilingual activity of interpreting in hospital encounters.
This article examines interpreters’ embodied displays of trouble in hospital encounters in Norway. In these meetings, participants speak different languages, and the interpreters, that is multilinguals with interpreter education and other formal qualifications, produce utterances in either of the languages in question. As such, the specific interaction in which these embodied displays of trouble occur is mediated in two ways, it is both interpreter-mediated and video-mediated. Video-recordings of hospital settings where the interpreting is carried out through use of video-technology are analyzed using multimodal conversation analysis. The interpreters’ embodied displays of trouble are found resemble recruitmens and are found to initiate repair. The article shows that while the embodied display of trouble might be a versatile device to initiate repair within the video-mediated environment, the video-mediated environment provides a complex interactional space for the perception of the embodied action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.